NCT00828113 - Long-term Varenicline Treatment for Smoking Cessation | Biotech Hunter

Enrollment

101

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

February 28, 2011

Conditions

Smoking

Interventions

DRUG

varenicline

Extension of 1 mg twice daily treatment to 52 weeks

DRUG

varenicline

Double-blind switch to placebo after 12 weeks of open-label therapy

BEHAVIORAL

Individual smoking cessation counseling

Brief (\<10 minutes) smoking cessation counseling delivered at clinic visits

Trial Locations (2)

Center for Tobacco Research and Intervention, Milwaukee

Center for Tobacco Research and Intervention, Madison